compare the efficacy and safety of intravenous iron sucrose versus chelated oral iron in the treatment of iron deficiency anemia late in pregnancy.
Women aged 18 years or more with established iron deficiency anemia ( Hb: 8-10 )
Pregnancy 26-34 weeks
Anemia due to other causes than iron deficiency anemia.
Recent blood transfusion (in the last 3 months ).
Allergy to iron.
Multiple pregnancy.
Chelated Iron
DrugTreatment will be started 24rh after initial visit women will be randomized used random sequence computer generated list in such a way that every patient had equal chance to be among any of the two groups either to group 1 , where they will receive I.V ferrous sucrose in the E.U in Women's Health Hospital Assuit University as an i.v infusion in 250 ml 0.9% sodium chloride slowly over 30 minutes. The total required dose of iron will be divided into three doses, which will be given every 3 days, and the maximum daily dose is 200mg ( 2 ampoules ).
Iron sucrose
Drugto group 2 where they will receive chelated oral iron, they will be given iron chelated amino acid containing 15 mg of elemental iron once daily for 6 weeks. the women will be advised to take 1 tab of iron chelated amino acid containing 15mg of elemental iron once daily with meals for 6 weeks from the day of recruitment.
Click on the lead sponsor to view all of their trials.
